367 related articles for article (PubMed ID: 34675168)
21. The Seroprevalence of SARS-CoV-2 Antibodies among HealthCare Workers in University Hospital in Krakow before the Era of Vaccination.
Żółtowska B; Barańska I; Jachowicz E; Sydor W; Maziarz B; Mydel K; Różańska A; Wizner B; Rosiński J; Kossowska M; Głomb K; Wójkowska-Mach J
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409727
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
[TBL] [Abstract][Full Text] [Related]
23. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration.
Markovic-Denic L; Zdravkovic M; Ercegovac M; Djukic V; Nikolic V; Cujic D; Micic D; Pekmezovic T;
J Infect Public Health; 2022 Jul; 15(7):739-745. PubMed ID: 35691217
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms.
Javed W; Abidi SHB; Baqar JB
BMC Infect Dis; 2022 May; 22(1):481. PubMed ID: 35596145
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.
Bouwman M; van Osch F; Crijns F; Trienekens T; Mehagnoul-Schipper J; van den Bergh JP; de Vries J
BMJ Open; 2021 Oct; 11(10):e051573. PubMed ID: 34663664
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
30. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.
Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C
Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682719
[TBL] [Abstract][Full Text] [Related]
31. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.
Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadisa A; Admasu D; Tesfaye E; Bates TA; Bulcha JT; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
BMC Infect Dis; 2022 Mar; 22(1):261. PubMed ID: 35296265
[TBL] [Abstract][Full Text] [Related]
32. Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital.
Galán MI; Velasco M; Casas ML; Goyanes MJ; Rodríguez-Caravaca G; Losa-García JE; Noguera C; Castilla V; ;
Enferm Infecc Microbiol Clin (Engl Ed); 2020 Dec; 40(6):302-9. PubMed ID: 33485676
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves.
de Visscher N; Holemans X; Gillain A; Kornreich A; Lagasse R; Piette P; Ventura M; Thys F
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891515
[No Abstract] [Full Text] [Related]
34. SARS-CoV-2 RT-PCR positivity and antibody prevalence among asymptomatic hospital-based health care workers.
Johnson CC; Coleman CM; Sitarik AR; Leon JE; Tibbetts RJ; Cook BC; Muma BK; Weinmann AJ; Samuel LP
J Clin Virol; 2021 Jul; 140():104794. PubMed ID: 34023573
[TBL] [Abstract][Full Text] [Related]
35. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic.
Rodriguez A; Arrizabalaga-Asenjo M; Fernandez-Baca V; Lainez MP; Al Nakeeb Z; Garcia JD; Payeras A
Int J Infect Dis; 2021 Apr; 105():482-486. PubMed ID: 33647507
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
Chasinga TB; Cikwanine JB; Kribi S; Yoyu JT; Hofmann N; Grossegesse M; Nitsche A; Tomczyk S; Vietor AC; Leendertz FH; Eckmanns T; Kusinza AB; Munguakonkwa E; Kalk A; Raha M; Kambale NS; Ayagirwe RB; Schubert G; Mukwege D
BMJ Open; 2024 Jan; 14(1):e072212. PubMed ID: 38176860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
